October 26, 2025

Get In Touch

Medanta signs MoU with the Korean Association to enhance healthcare services

New Delhi:Medanta- one of India's leading super-speciality hospitals, ranked the Best Private Hospital in India by Newsweek for six consecutive years, has signed a two-year partnership with The Korean Association in India to extend world-class healthcare services to Korean members of the association residing in India. The Memorandum of Understanding (MoU) was formalized at Medanta in the last week of September in the presence ofDr Naresh Trehan, Chairman & Managing Director,Medanta, and Mr. Kwang-Il Lee, President, The Korean Association in India, along with senior representatives from both organizations. Under this partnership,Medantawill provide a comprehensive range of healthcare, including OPD consultations, Executive Preventive Health Check-ups (EHC), and inpatient care. To ensure a seamless experience, a dedicated Korean helpdesk and helpline will be established, supported by a relationship manager to facilitate coordination and assistance. Members will also benefit from green-channel registration and VIP tagging to streamline hospital processes. Also Read:Medanta Expands footprint with 550-bed Super Specialty Hospital in Noida This collaboration underscores Medanta’s commitment to providing personalised, compassionate, and accessible healthcare to diverse communities living in India, creating an inclusive ecosystem of care. The initiative is a significant step toward fostering international cooperation in healthcare and ensuring that Korean residents in India receive quality medical care in a comfortable and culturally aligned environment. About Global Health Limited (Medanta): Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest civilian awards in India, and the Dr. B.C. Roy Award in recognition of his distinguished contribution to medicine. Global Health Limited (the “Company”) is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology, according to the report titled “An assessment of the healthcare delivery market in India, September 2022” by CRISIL Limited. Under the “Medanta” brand, the Company has a network of six hospitals currently in operation (Gurgaon, Indore, Ranchi, Lucknow, Patna and Noida). Spanning an area of 5.5 million sq. ft., its operational hospitals have 3,362 installed beds as on September 01, 2025. Additionally, four hospitals with a planned bed capacity of approximately 2,000 are in various stages of planning or construction in Mumbai, New Delhi (Pitampura), South Delhi (GK), and Guwahati. The Company provides healthcare services in over 30 medical specialties and engages over 2,000 + doctors led by highly experienced department heads. Also Read:Medanta appoints Dr Pawan Rawal as Senior Director of Gastroenterology

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!